SONIDA SENIOR LIVING, INC. (SNDA)

Data as of Sep 4, 2026, from SEC Form 4 filings.

NYSEServices-Nursing & Personal Care FacilitiesNet insider selling (90d)Watch SNDA

See up to 3 months of SNDA. The 7-day demo opens the 1M and 3M ranges and puts SNDA on your watchlist.

Latest SNDA insider trades

Michael Simanovsky - Director
Open-market sale$832K
Aug 28, 2026
Michael Simanovsky - Director

About SONIDA SENIOR LIVING, INC. (SNDA)

Sonida Senior Living Inc is an owner-operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic services offered by the company at its senior housing communities comprise meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.

Headquarters: DALLAS, TX
Employees: 5,140
Listed: 1997
Exchange: NYSE
Sector: Health Care

https://www.sonidaseniorliving.com SEC filings for SNDA on EDGAR

SNDA Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Open-market sale	8	275,343	$10.90M
Grant or award	12	4,894,716
Option exercise	8	3,285,510

SNDA insider transactions (Form 4)

58 Form 4 filings on record, the earliest from Oct 17, 2024, newest first. Filing history page 1 of 2.

Traded	Insider	Transaction	Security	Shares	Price	Value
Mar 11, 2026	Michael Simanovsky - Director	Grant or award	Common Stock	1,592,406	$26.74	$42.58M
Mar 11, 2026	Michael Simanovsky - Director	Grant or award	Common Stock	87,530	$26.74	$2.34M
Mar 11, 2026	Michael Simanovsky - Director	Grant or award	Common Stock	224,829	$26.74	$6.01M
Mar 11, 2026	Michael Simanovsky - Director	Grant or award	Common Stock	1,834,951	$26.74	$49.07M
Mar 11, 2026	Michael Simanovsky - Director	Option exercise	Common Stock	1,504,134	$32.00	$48.13M
Mar 11, 2026	Michael Simanovsky - Director	Option exercise	Common Stock	97,371	$32.00	$3.12M
Mar 11, 2026	Michael Simanovsky - Director	Derivative	Series A Convertible Preferred Stock	38,742^{footnote F1}	-^{footnote F12}	-
Mar 11, 2026	Michael Simanovsky - Director	Derivative	Series A Convertible Preferred Stock	2,508^{footnote F1}	-^{footnote F12}	-
Mar 11, 2026	Michael Simanovsky - Director	Grant or award	Series A Convertible Preferred Stock	38,742	-^{footnote F12}	-
Mar 11, 2026	Michael Simanovsky - Director	Grant or award	Series A Convertible Preferred Stock	2,508	-^{footnote F12}	-
Mar 11, 2026	Michael Simanovsky - Director	Option exercise	Series A Convertible Preferred Stock	38,742^{footnote F1}	$0.00	-
Mar 11, 2026	Michael Simanovsky - Director	Option exercise	Series A Convertible Preferred Stock	2,508^{footnote F1}	$0.00	-
Mar 11, 2026	Michael Simanovsky - Director	Derivative	Warrant	968,538^{footnote F1}	-^{footnote F12}	-
Mar 11, 2026	Michael Simanovsky - Director	Derivative	Warrant	62,712^{footnote F1}	-^{footnote F12}	-
Mar 11, 2026	Michael Simanovsky - Director	Grant or award	Warrant	968,538	-^{footnote F12}	-
Mar 11, 2026	Michael Simanovsky - Director	Grant or award	Warrant	62,712	-^{footnote F12}	-
Footnote F1 (shares): This Form 4/A amends and restates the March 13, 2026 Form 4 filed jointly by Michael Simanovsky, a United States citizen; Conversant Capital LLC, a Delaware limited liability company ("Conversant Capital"); Conversant GP Holdings LLC, a Delaware limited liability company… Full note on SEC EDGAR Footnote F12 (price): On March 11, 2026, the Issuer agreed with each of Investor A and Investor B to (i) amend the shares of Series A Convertible Preferred Stock to reduce the conversion price to $32 per share of Common Stock, (ii) make a onetime payment of approximately $5.8 million in the… Full note on SEC EDGAR
Aug 28, 2026	Michael Simanovsky - Director	Open-market sale	Common Stock	21,792	$38.16^{footnote F11}	$832K
Aug 28, 2026	Michael Simanovsky - Director	Open-market sale	Common Stock	4,615	$39.25^{footnote F12}	$181K
Sep 1, 2026	Michael Simanovsky - Director	Open-market sale	Common Stock	97,581	$38.42^{footnote F13}	$3.75M
Footnote F11 (price): Price is the volume weighted average selling price of all sales by the seller on the indicated transaction date. Actual prices ranged from $38.01 to $39.00. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the issuer, or a security holder… Full note on SEC EDGAR Footnote F12 (price): Price is the volume weighted average selling price of all sales by the seller on the indicated transaction date. Actual prices ranged from $39.09 to $39.31. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the issuer, or a security holder… Full note on SEC EDGAR Footnote F13 (price): Price is the volume weighted average selling price of all sales by the seller on the indicated transaction date. Actual prices ranged from $38.00 to $38.79. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the issuer, or a security holder… Full note on SEC EDGAR
Aug 25, 2026	Michael Simanovsky - Director	Open-market sale	Common Stock	115,000	$40.71^{footnote F1}	$4.68M
Aug 26, 2026	Michael Simanovsky - Director	Open-market sale	Common Stock	15,086	$40.94^{footnote F3}	$618K
Aug 27, 2026	Michael Simanovsky - Director	Open-market sale	Common Stock	15,000	$39.00	$585K
Footnote F1 (price): Price is the volume weighted average selling price of all sales by the seller on the indicated transaction date. Actual prices ranged from $40.50 to $41.00. The Reporting Persons (as defined below) hereby undertake to provide upon request of the Commission staff, the issuer, or… Full note on SEC EDGAR Footnote F3 (price): Price is the volume weighted average selling price of all sales by the seller on the indicated transaction date. Actual prices ranged from $40.50 to $41.40. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the issuer, or a security holder… Full note on SEC EDGAR
Aug 21, 2026	Michael Simanovsky - Director	Other	Common Stock	1,182,595	$0.00^{footnote F1}	-
Footnote F1 (price): On August 21, 2026, at the request of certain CPIF Sparti SAF, LP, a Delaware limited partnership ("CPIF SAF") limited partners unaffiliated with the Reporting Persons, and in satisfaction of pre-existing obligations of Conversant Private GP LLC, a Delaware limited liability… Full note on SEC EDGAR
Aug 14, 2026	Benjamin P. Harris - Director	Open-market sale	Common Stock	3,074	$39.79	$122K
Aug 14, 2026	Benjamin P. Harris - Director	Open-market sale	Common Stock	3,195	$39.79	$127K
Aug 10, 2026	Michael Simanovsky - Director	Derivative	Common Stock	1,504,134	-^{footnote F6}	-
Aug 10, 2026	Michael Simanovsky - Director	Derivative	Common Stock	97,371	-^{footnote F6}	-
Aug 10, 2026	Michael Simanovsky - Director	Option exercise	Common Stock	1,504,134	$32.00	$48.13M
Aug 10, 2026	Michael Simanovsky - Director	Option exercise	Common Stock	97,371	$32.00	$3.12M
Aug 10, 2026	Michael Simanovsky - Director	Grant or award	Series A Convertible Preferred Stock	38,742	-^{footnote F1}	-
Aug 10, 2026	Michael Simanovsky - Director	Grant or award	Series A Convertible Preferred Stock	2,508	-^{footnote F1}	-
Aug 10, 2026	Michael Simanovsky - Director	Derivative	Series A Convertible Preferred Stock	38,742	-^{footnote F1}	-
Aug 10, 2026	Michael Simanovsky - Director	Derivative	Series A Convertible Preferred Stock	2,508	-^{footnote F1}	-
Aug 10, 2026	Michael Simanovsky - Director	Grant or award	Series B Convertible Preferred Stock	38,742	-^{footnote F1}	-
Aug 10, 2026	Michael Simanovsky - Director	Grant or award	Series B Convertible Preferred Stock	2,508	-^{footnote F1}	-
Aug 10, 2026	Michael Simanovsky - Director	Option exercise	Series B Convertible Preferred Stock	38,742	-^{footnote F1}	-
Aug 10, 2026	Michael Simanovsky - Director	Option exercise	Series B Convertible Preferred Stock	2,508	-^{footnote F1}	-
Footnote F1 (price): On August 10, 2026, the Issuer filed certificates of correction to the March 11, 2026 Certificate of Elimination and Certificate of Designation Amendment, pursuant to which the Issuer, in accordance with Exchange Act Rule 16b-3 ("Rule 16b-3") and the agreement of the Reporting… Full note on SEC EDGAR Footnote F6 (price): There is no expiration date for the right of the holder of Series A Convertible Preferred Stock to convert.
Jul 1, 2026	Anton D. Nikodemus - Officer	Grant or award	Common Stock	12,118^{footnote F1}	$0.00	-
Jul 1, 2026	Anton D. Nikodemus - Officer	Grant or award	Performance Units	75,000	$0.00	-
Footnote F1 (shares): Reflects a grant of restricted stock units ("RSUs") that was made to the reporting person on July 1, 2026 and that will vest equally over a three-year period on each anniversary of the grant date.
Jun 11, 2026	Benjamin P. Harris - Director	Grant or award	Common Stock	7,124^{footnote F1}	$0.00	-
Footnote F1 (shares): Reflects a grant of restricted stock units ("RSUs") that will vest in full on June 11, 2027, which is the first anniversary of the grant date, subject to the director continuing as a member of the Issuer's Board of Directors until such time.
Jun 11, 2026	Stephen H. Mauldin - Director	Grant or award	Common Stock	4,132^{footnote F1}	$0.00	-
Footnote F1 (shares): Reflects a grant of restricted stock units ("RSUs") that will vest in full on June 11, 2027, which is the first anniversary of the grant date, subject to the director continuing as a member of the Issuer's Board of Directors until such time.
Jun 11, 2026	Lilly Donohue - Director	Grant or award	Common Stock	4,132^{footnote F1}	$0.00	-
Footnote F1 (shares): Reflects a grant of restricted stock units ("RSUs") that will vest in full on June 11, 2027, which is the first anniversary of the grant date, subject to the director continuing as a member of the Issuer's Board of Directors until such time.
Jun 11, 2026	Jill M. Krueger - Director	Grant or award	Common Stock	4,132^{footnote F1}	$0.00	-
Footnote F1 (shares): Reflects a grant of restricted stock units ("RSUs") that will vest in full on June 11, 2027, which is the first anniversary of the grant date, subject to the director continuing as a member of the Issuer's Board of Directors until such time.
Jun 11, 2026	J. Chandler Martin - Director	Grant or award	Common Stock	4,132^{footnote F1}	$0.00	-
Footnote F1 (shares): Reflects a grant of restricted stock units ("RSUs") that will vest in full on June 11, 2027, which is the first anniversary of the grant date, subject to the director continuing as a member of the Issuer's Board of Directors until such time.
May 13, 2026	Benjamin P. Harris - Director	Open-market sale	Common Stock	2,500	$37.46	$94K
Jun 11, 2026	Sam Levinson - Director	Grant or award	Common Stock	6,412	$0.00	-
May 19, 2026	Max Levy - Officer	Tax withholding / forfeiture	Common Stock	1,405	$36.94	$52K
May 19, 2026	Tabitha Bailey - Officer	Tax withholding / forfeiture	Common Stock	432^{footnote F1}	$36.94	$16K
Footnote F1 (shares): Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.
May 19, 2026	Timothy Cober - Officer	Tax withholding / forfeiture	Common Stock	346^{footnote F1}	$36.94	$13K
Footnote F1 (shares): Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.
May 19, 2026	Max Levy - Officer	Tax withholding / forfeiture	Common Stock	1,363^{footnote F1}	$36.94	$50K
Footnote F1 (shares): Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.
May 19, 2026	Brandon Ribar - Officer	Tax withholding / forfeiture	Common Stock	3,067^{footnote F1}	$36.94	$113K
Footnote F1 (shares): Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.
May 19, 2026	Kevin Detz - Officer	Tax withholding / forfeiture	Common Stock	1,952^{footnote F1}	$36.94	$72K
Footnote F1 (shares): Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.
Apr 5, 2026	Kevin Detz - Officer	Tax withholding / forfeiture	Common Stock	4,461^{footnote F1}	$32.18	$144K
Apr 17, 2026	Kevin Detz - Officer	Grant or award	Common Stock	12,723^{footnote F2}	$0.00	-
Footnote F1 (shares): Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations. Footnote F2 (shares): Reflects a grant of restricted stock units ("RSUs") that was made to the reporting person on April 17, 2026 and that will vest equally over a three-year period on each anniversary of the grant date.
Apr 5, 2026	Brandon Ribar - Officer	Tax withholding / forfeiture	Common Stock	7,010^{footnote F1}	$32.18	$226K
Apr 17, 2026	Brandon Ribar - Officer	Grant or award	Common Stock	23,023^{footnote F2}	$0.00	-
Footnote F1 (shares): Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations. Footnote F2 (shares): Reflects a grant of restricted stock units ("RSUs") that was made to the reporting person on April 17, 2026 and that will vest equally over a three-year period on each anniversary of the grant date.
Apr 17, 2026	Max Levy - Officer	Grant or award	Common Stock	8,482^{footnote F1}	$0.00	-
Footnote F1 (shares): Reflects a grant of restricted stock units ("RSUs") that was made to the reporting person on April 17, 2026 and that will vest equally over a three-year period on each anniversary of the grant date.
Apr 5, 2026	Timothy Cober - Officer	Tax withholding / forfeiture	Common Stock	593^{footnote F1}	$32.18	$19K
Apr 17, 2026	Timothy Cober - Officer	Grant or award	Common Stock	3,635^{footnote F2}	$0.00	-
Footnote F1 (shares): Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations. Footnote F2 (shares): Reflects a grant of restricted stock units ("RSUs") that was made to the reporting person on April 17, 2026 and that will vest equally over a three-year period on each anniversary of the grant date.
Apr 17, 2026	Tabitha Bailey - Officer	Grant or award	Common Stock	4,847^{footnote F1}	$0.00	-
Footnote F1 (shares): Reflects a grant of restricted stock units ("RSUs") that was made to the reporting person on April 17, 2026 and that will vest equally over a three-year period on each anniversary of the grant date.
Dec 9, 2025	Tabitha Bailey - Officer	Tax withholding / forfeiture	Common Stock	402^{footnote F1}	$30.43	$12K
Feb 23, 2026	Tabitha Bailey - Officer	Grant or award	Performance Units	55,000	$0.00	-
Footnote F1 (shares): Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.
Mar 9, 2026	Kevin Detz - Officer	Derivative	Common Stock	9,134^{footnote F1}	$0.00	-
Mar 9, 2026	Kevin Detz - Officer	Tax withholding / forfeiture	Common Stock	2,917^{footnote F3}	$36.64	$107K
Feb 23, 2026	Kevin Detz - Officer	Grant or award	Performance Units	185,000	$0.00	-
Footnote F1 (shares): Represents shares of performance-based restricted stock that were previously reported as beneficially owned by the reporting person as of April 4, 2023, but were subsequently forfeited due to the Company only partially achieving the performance target with respect to such shares… Full note on SEC EDGAR Footnote F3 (shares): Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.
Mar 9, 2026	Brandon Ribar - Officer	Derivative	Common Stock	14,353^{footnote F1}	$0.00	-
Mar 9, 2026	Brandon Ribar - Officer	Tax withholding / forfeiture	Common Stock	6,472^{footnote F3}	$36.64	$237K
Feb 23, 2026	Brandon Ribar - Officer	Grant or award	Performance Units	275,000	$0.00	-
Footnote F1 (shares): Represents shares of performance-based restricted stock that were previously reported as beneficially owned by the reporting person as of April 4, 2023, but were subsequently forfeited due to the Company only partially achieving the performance target with respect to such shares… Full note on SEC EDGAR Footnote F3 (shares): Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.
Feb 23, 2026	Max Levy - Officer	Grant or award	Performance Units	130,000	$0.00	-
Mar 9, 2026	Timothy Cober - Officer	Derivative	Common Stock	1,957^{footnote F1}	$0.00	-
Mar 9, 2026	Timothy Cober - Officer	Tax withholding / forfeiture	Common Stock	547^{footnote F3}	$36.64	$20K
Feb 23, 2026	Timothy Cober - Officer	Grant or award	Performance Units	55,000	$0.00	-
Footnote F1 (shares): Represents shares of performance-based restricted stock that were previously reported as beneficially owned by the reporting person as of April 4, 2023, but were subsequently forfeited due to the Company only partially achieving the performance target with respect to such shares… Full note on SEC EDGAR Footnote F3 (shares): Represents shares that were withheld upon vesting of restricted stock to satisfy tax withholding obligations.

Recent SNDA Form 8-K filings

Read SNDA company news

Oct 7, 2026Item 5.03, 9.01

Read the filing on SEC EDGAR

Aug 17, 2026Item 8.01, 9.01

Read the filing on SEC EDGAR

Aug 13, 2026Item 1.01, 2.03, 9.01

Read the filing on SEC EDGAR

Aug 10, 2026Item 1.01, 3.02, 3.03, 5.03, 9.01

Congress trades in SNDA

All congress trades

Stock trades in SNDA disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.

Member	Type	Traded	Disclosed	Value range	Owner	Days to disclose	Filing
Rick LarsenDemocrat, WA-02	Exchange

SNDA insider trading FAQ

What is the latest insider trade for SNDA?

SONIDA SENIOR LIVING, INC. (SNDA) had 6 insider filings in the last 90 days, with the most recent on 4 September 2026. The full record for SNDA runs to 58 Form 4 filings, the earliest from 17 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying SNDA stock?

No insider purchases of SNDA were filed in the last 90 days. 16 purchases are on record for this company.

How many insiders are selling SNDA stock?

8 insider sales of SNDA were filed in the last 90 days, totaling $10.90M.

Where can I see SNDA SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects SNDA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Sep 4, 2026 - Michael Simanovsky view on EDGAR
Sep 2, 2026 - Michael Simanovsky view on EDGAR
Aug 28, 2026 - Michael Simanovsky view on EDGAR
Aug 25, 2026 - Michael Simanovsky view on EDGAR
Aug 19, 2026 - Benjamin P. Harris view on EDGAR
Aug 11, 2026 - Michael Simanovsky view on EDGAR
Jul 6, 2026 - Anton D. Nikodemus view on EDGAR
Jun 16, 2026 - Benjamin P. Harris view on EDGAR
Jun 16, 2026 - Stephen H. Mauldin view on EDGAR

Related companies with recent insider activity

Learn more

Insider selling: signal or noise?: Why most insider sales are routine, and the few patterns worth a second look.
Insider activity in Health Care: Where SNDA's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow SNDA with a 7-day demo

SNDA on your watchlist
Every SNDA Form 4 filing on record
Up to 3 months of SNDA price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Open-market sale

275,343

$10.90M

Grant or award

4,894,716

Option exercise

3,285,510

Traded

Insider

Transaction

Security

Price

Value

Mar 11, 2026